News & Updates
Filter by Specialty:
Response to therapy higher in clinical trial than real-world RCC patients
Among patients with metastatic renal cell carcinoma (RCC) who have received first-line therapies, complete response rates are lower in the real-world population than in the clinical trial population, reports a recent study. Complete response predicts a favourable overall survival.
Response to therapy higher in clinical trial than real-world RCC patients
22 Mar 2023Menopausal hormone therapy use carries increased T2DM risk
The use of menopausal hormone therapy (MHT), including the most prescribed agent tibolone, appears to contribute to an increase in the risk of type 2 diabetes mellitus (T2DM), as shown in a retrospective study.
Menopausal hormone therapy use carries increased T2DM risk
21 Mar 2023Neurologic disability predicts severe ED in men infected with HTLV-1
Patients with human T-lymphotropic virus 1 (HTLV-1) infection may develop erectile dysfunction (ED), and time to progression to its severe form is significantly associated with the degree of neurologic compromise at baseline, reveals a study.
Neurologic disability predicts severe ED in men infected with HTLV-1
21 Mar 2023CBT, mindfulness help improve sexual outcomes in prostate cancer
Mindfulness and cognitive behavioural therapy (CBT) appear beneficial for prostate cancer survivors and their partners who are dealing with sexual dysfunction, a study has shown.